|
MEMO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.803600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.361400E-01 |
| Normal-vs-Stage2 |
2.430400E-02 |
| Normal-vs-Stage3 |
2.989800E-01 |
| Normal-vs-Stage4 |
6.030800E-01 |
| Stage1-vs-Stage2 |
4.076300E-02 |
| Stage1-vs-Stage3 |
2.875800E-01 |
| Stage1-vs-Stage4 |
5.947200E-01 |
| Stage2-vs-Stage3 |
5.532800E-01 |
| Stage2-vs-Stage4 |
8.960600E-01 |
| Stage3-vs-Stage4 |
9.033200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.344600E-01 |
| Normal-vs-AfricanAmerican |
5.567400E-01 |
| Normal-vs-Asian |
1.077980E-01 |
| Caucasian-vs-AfricanAmerican |
5.884600E-01 |
| Caucasian-vs-Asian |
4.934200E-02 |
| AfricanAmerican-vs-Asian |
9.179900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.039600E-01 |
| Normal-vs-Female |
5.756300E-04 |
| Male-vs-Female |
1.83576999999158E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.904370E-01 |
| Normal-vs-Extreme_Weight |
1.350780E-01 |
| Normal-vs-Obese |
5.865600E-01 |
| Normal-vs-Extreme_Obese |
5.443600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.204400E-02 |
| Normal_Weight-vs-Obese |
3.853400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.473000E-01 |
| Extreme_Weight-vs-Obese |
9.881600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.344210E-01 |
| Obese-vs-Extreme_Obese |
7.113800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.058570E-01 |
| Normal-vs-Age(41-60Yrs) |
3.524000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.577600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.054810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.444800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.449800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.164200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.996200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.304390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.591000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.588400E-02 |
| Normal-VS-Type2 PRCC |
3.219200E-01 |
| Normal-VS-KIRP CIMP |
2.367900E-02 |
| Normal-VS-Unclassified PRCC |
2.173400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.049700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.839000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.444400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.472200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.366000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.511500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.986800E-01 |
| Normal-vs-N1 |
1.733030E-01 |
| Normal-vs-N2 |
9.828400E-01 |
| N0-vs-N1 |
1.454750E-01 |
| N0-vs-N2 |
9.229800E-01 |
| N1-vs-N2 |
5.694600E-01 |
|
|
